Related Experiment Video

Updated: Jun 25, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Viral hepatitis C

Jacek Czepiel1, Grazyna Biesiada, Tomasz Mach

  • 1Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College, Kraków, Poland. jacz@op.pl

Polskie Archiwum Medycyny Wewnetrznej
|February 11, 2009
PubMed

Insights

Hepatitis C virus (HCV) infection affects millions globally, often asymptomatic initially. Treatment effectiveness for HCV varies by genotype, with higher cure rates for genotypes 2 and 3 compared to genotype 1.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern, affecting approximately 170 million people worldwide.
  • The majority of acute HCV infections are asymptomatic, with a high progression rate to chronic hepatitis C.
  • Chronic hepatitis C can lead to severe liver conditions, including cirrhosis.

Purpose of the Study:

  • To summarize the epidemiology, clinical presentation, diagnosis, and treatment of Hepatitis C virus infection.
  • To highlight the impact of HCV genotypes on disease progression and treatment outcomes.

Main Methods:

  • Review of epidemiological data from the World Health Organization.
  • Description of diagnostic methods including ELISA for anti-HCV antibodies and RT-PCR for HCV-RNA.
  • Overview of current treatment regimens involving pegylated interferon alfa and ribavirin.

Main Results:

  • HCV infection often presents with non-specific symptoms in the acute phase, progressing to chronic disease in 70-80% of cases.
  • Diagnostic tools include antibody detection (ELISA) and viral RNA quantification (RT-PCR).
  • Treatment success rates vary by genotype: 78% for genotypes 2 and 3, and 55% for genotype 1.

Conclusions:

  • Hepatitis C requires timely diagnosis and genotype-specific treatment for effective management.
  • Understanding HCV epidemiology and treatment outcomes is crucial for public health strategies.
  • Further research may improve treatment efficacy across all HCV genotypes.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...